BNP Paribas Easy (BLUE) | Financial Analysis & Statements
BNP Paribas Easy ECPI Global ESG Blue Economy UCITS ETF Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2018Income Metrics
EPS (Diluted)
€0.00
Balance Sheet Metrics
Total Assets
185.7M
Total Liabilities
141.2M
Shareholders Equity
44.5M
Debt to Equity
3.18
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2019
BNP Paribas Easy Income Statement From 2015 to 2019
| Metric | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|
| Revenue | 26.4M | 38.2M | 80.7M | 109.3M | 121.9M |
| Cost of Goods Sold | 33.6M | 34.6M | 61.3M | 69.5M | 81.3M |
| Gross Profit | -7.2M | 3.6M | 19.4M | 39.9M | 40.5M |
| Gross Margin % | -27.2% | 9.4% | 24.0% | 36.5% | 33.3% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | - | - | - | - |
| Other Operating Expenses | -10.2M | -9.5M | -9.0M | -8.4M | -7.7M |
| Total Operating Expenses | -10.2M | -9.5M | -9.0M | -8.4M | -7.7M |
| Operating Income | -41.4M | -30.4M | -19.7M | -299.0K | 3.8M |
| Operating Margin % | -157.0% | -79.5% | -24.4% | -0.3% | 3.1% |
| Non-Operating Items | |||||
| Interest Income | - | 1.0K | 11.0K | 51.0K | 59.0K |
| Interest Expense | 916.0K | 663.0K | 696.0K | 688.0K | 696.0K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -42.3M | -32.7M | -21.2M | 1.3M | 508.0K |
| Income Tax | 568.0K | 690.0K | -2.0M | 1.3M | 488.0K |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 106.4% | 96.1% |
| Net Income | -42.9M | -33.4M | -19.2M | -80.0K | 20.0K |
| Net Margin % | -162.5% | -87.3% | -23.8% | -0.1% | 0.0% |
| Key Metrics | |||||
| EBITDA | -24.0M | -16.9M | -4.7M | 17.4M | 18.7M |
| EPS (Basic) | - | €-1.14 | €-0.67 | €0.00 | €0.00 |
| EPS (Diluted) | - | €-1.14 | €-0.67 | €0.00 | €0.00 |
| Basic Shares Outstanding | - | 29152656 | 28838316 | 28838316 | 28838316 |
| Diluted Shares Outstanding | - | 29152656 | 28838316 | 28838316 | 28838316 |
Income Statement Trend
BNP Paribas Easy Balance Sheet From 2015 to 2019
| Metric | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 3.6M | 4.4M | 3.5M | 12.5M | 16.9M |
| Short-term Investments | 4.0K | 4.0K | 17.0K | - | - |
| Accounts Receivable | 1.1M | 879.0K | 7.5M | 8.9M | 12.3M |
| Inventory | 17.3M | 12.3M | 12.3M | 22.1M | 22.7M |
| Other Current Assets | 1.0K | - | - | - | - |
| Total Current Assets | 34.7M | 30.0M | 35.9M | 54.1M | 62.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 18.0M | 23.9M | 23.4M | 21.6M | 19.1M |
| Goodwill | 49.8M | 45.5M | 41.2M | 53.7M | 5.6M |
| Intangible Assets | 20.0M | 16.3M | 13.2M | 4.1M | 4.5M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | -2.0K | - | - | - | - |
| Total Non-Current Assets | 151.0M | 145.1M | 149.3M | 157.0M | 133.0M |
| Total Assets | 185.7M | 175.1M | 185.1M | 211.2M | 195.9M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 5.9M | 6.6M | 5.4M | 6.9M | 11.6M |
| Short-term Debt | 60.9M | 18.1M | 8.0K | 307.0K | 895.0K |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 798.0K | 481.0K | 307.0K | 338.0K | 318.0K |
| Total Current Liabilities | 82.2M | 41.9M | 21.4M | 19.9M | 22.5M |
| Non-Current Liabilities | |||||
| Long-term Debt | 37.8M | 32.6M | 34.4M | 34.6M | 35.0M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.7M | 924.0K | 8.1M | 14.9M | 632.0K |
| Total Non-Current Liabilities | 59.1M | 45.5M | 45.9M | 52.9M | 37.7M |
| Total Liabilities | 141.2M | 87.4M | 67.3M | 72.8M | 60.2M |
| Equity | |||||
| Common Stock | 145.8M | 145.8M | 144.2M | 144.2M | 144.2M |
| Retained Earnings | - | - | - | - | - |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 44.5M | 87.7M | 117.8M | 138.4M | 135.7M |
| Key Metrics | |||||
| Total Debt | 98.7M | 50.7M | 34.4M | 34.9M | 35.9M |
| Working Capital | -47.5M | -11.9M | 14.4M | 34.3M | 40.4M |
Balance Sheet Composition
BNP Paribas Easy Cash Flow Statement From 2015 to 2019
| Metric | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -42.9M | -33.4M | -19.2M | -80.0K | 20.0K |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -5.4M | 4.7M | 7.9M | 6.3M | -6.6M |
| Operating Cash Flow | -47.4M | -26.2M | -8.1M | 5.5M | -2.0M |
| Investing Activities | |||||
| Capital Expenditures | -8.9M | -6.0M | -12.0M | -15.6M | -15.1M |
| Acquisitions | 0 | - | - | - | - |
| Investment Purchases | -1.0K | -5.0K | -32.0K | -101.0K | -100.0K |
| Investment Sales | 33.0K | 45.0K | 125.0K | 0 | 1.0K |
| Investing Cash Flow | -8.8M | -5.5M | -11.9M | -23.4M | -15.2M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | - | - | - | - | - |
| Financing Cash Flow | 1.3M | 1.3M | - | - | 59.0K |
| Free Cash Flow | -42.7M | -19.0M | -9.0M | 1.7M | 2.0M |
| Net Change in Cash | -54.9M | -30.4M | -20.0M | -17.8M | -17.1M |
Cash Flow Trend
BNP Paribas Easy Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
22.65
Price to Sales
19.99
Profitability Ratios
Profit Margin
-27.22%
Operating Margin
-156.86%
Return on Equity
-96.39%
Return on Assets
-23.08%
Financial Health
Current Ratio
0.42
Debt to Equity
2.22
Per Share Data
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| BLUE | 527.3M | 22.65 | - | -96.39% | -27.22% | 2.22 |
| Abivax SA | 7.6B | -19.88 | 16.56 | -135.58% | 0.00% | 7.05 |
| Nanobiotix | 1.4B | - | - | 28.36% | -73.52% | -1.13 |
| Medincell S.A | 831.6M | -37.35 | - | 112.65% | -61.49% | -2.40 |
| Valneva SE | 416.1M | 70.64 | 3.91 | -80.16% | -65.95% | 195.21 |
Financial data is updated regularly. All figures are in the company's reporting currency.